Vave Health is a technology company.
Vave Health has raised $2.0M across 1 funding round.
Vave Health has raised $2.0M in total across 1 funding round.
Vave Health is a medical technology company headquartered in San Jose, California, specializing in portable ultrasound imaging devices to make high-quality diagnostics accessible, affordable, and simple at the point of care.[1][2][4] It builds the Vave Universal Wireless Probe, a handheld, whole-body ultrasound device using a single gold-standard PZT (piezoelectric) transducer that supports multiple modes including B-mode, Deep mode, M-mode, and Color-Doppler, pairing wirelessly with iOS or Android devices via an intuitive app.[1][3][6] The product serves clinicians, hospitals, medical schools, and providers in underserved areas, solving the problem of bulky, expensive ultrasound systems by offering a lightweight (340g), waterproof, subscription-free probe with swappable batteries, auto-adjust imaging (V-Beam technology), and HIPAA-compliant cloud sharing for rapid, reliable scans across specialties like abdominal, cardiac, vascular, and OB/GYN.[2][3][7] Growth momentum includes partnerships like with the Inteleos Foundation for global deployment in low- and middle-income countries (LMICs) under $3,000 bundles with training, plus endorsements from universities and clinicians highlighting superior image quality and no ongoing fees compared to competitors.[3][4]
Vave Health was founded by Amin Nikoozadeh, a Stanford University Ph.D. with expertise in miniaturizing imaging systems, driven by a mission to deliver state-of-the-art, ultraportable ultrasound for cost-effective point-of-care imaging.[4][8] The idea emerged from advancing portable diagnostic tools to break barriers in healthcare, particularly for underserved providers, evolving into the world's first wireless handheld whole-body ultrasound with a single PZT transducer.[1][6][8] Early traction built through product iterations emphasizing hardware/software improvements for better images across body types, clinician feedback on versatility, and milestones like the Universal Probe launch, plus 9 patents in medical imaging and physics; pivotal moments include the Inteleos partnership for LMIC expansion and adoption in medical curricula at institutions like University of Arizona and Touro University Nevada.[1][3][4]
Vave Health rides the point-of-care ultrasound (POCUS) trend, fueled by miniaturization tech and AI-adjacent imaging advances, enabling diagnostics anywhere from rural clinics to urban hospitals amid rising demand for rapid, bedside decisions.[1][7] Timing aligns with global healthcare gaps in LMICs and post-pandemic decentralization, where portable devices cut diagnosis delays (e.g., heart failure cases) and support maternal health or workforce training; market forces like cost pressures and clinician shortages favor its no-subscription model over rivals like Exo or Emagine.[1][3][4] It influences the ecosystem by partnering for bundled training/certification (e.g., Inteleos), integrating into med school curricula, and collecting longitudinal data to scale ultrasound programs, democratizing high-quality imaging beyond traditional cart-based systems.[3][4]
Vave Health is poised to dominate affordable POCUS with global expansions via partnerships, potentially capturing medtech market share in emerging regions through data-driven impact assessments and sustained innovation (e.g., more patents, software enhancements).[1][4] Trends like AI imaging integration, telehealth growth, and LMIC investments will shape its path, amplifying influence as the "limitless ultrasound" standard for equitable diagnostics. This builds on its core promise: transforming healthcare by putting precision in every provider's pocket, much like its founding vision to make imaging simple and ubiquitous.[2][6]
Vave Health has raised $2.0M in total across 1 funding round.
Vave Health's investors include BlueRun Ventures, Cota Capital, DNX Ventures, Innovius Capital, NewView Capital, Streamlined Ventures.
Vave Health has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in April 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2015 | $2.0M Seed | BlueRun Ventures, Cota Capital, DNX Ventures, Innovius Capital, NewView Capital, Streamlined Ventures |